Steering Committee

PILOT™ Work Group:
Clinical Tools for the Primary Care Physician and Resources for Patient Management and Education

Objectives

• Demonstrate the differences between IPF and other interstitial lung diseases (ILD)
• Identify the importance of early referrals to pulmonologists for potential IPF patients
• Review important disease and treatment information for physicians to discuss with IPF patients

Jeffrey A. Golden, MD (lead)
University of California at San Francisco
San Francisco, California

Yolanda N. Mageto, MD
The University of Texas Southwestern Medical Center at Dallas
Dallas, Texas

Imre Noth, MD
The University of Chicago
Chicago, Illinois

Glenn D. Rosen, MD
Stanford University School of Medicine
Stanford, California

Steven A. Sahn, MD
Medical University of South Carolina
Charleston, South Carolina

Mark A. Shreve
Coalition for Pulmonary Fibrosis
San Jose, California